ARUNJYOTI BIO VENTURES
|
ARUNJYOTI BIO VENTURES Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -1.68 | 0.56 | 0.27 | 0.33 | 0.51 |
| CEPS(Rs) | 8.04 | 0.10 | 0.05 | 0.06 | 0.09 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 8.53 | 10.22 | 9.66 | 9.39 | 9.06 |
| Tax Rate(%) | 73.13 | 26.03 | 26.00 | 26.00 | 19.24 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 13.62 | 9.53 | -6.83 | 1.75 | 1.78 |
| EBIT Margin(%) | 3.95 | 9.53 | 2.59 | 1.78 | 1.81 |
| Pre Tax Margin(%) | -6.36 | 9.10 | 2.56 | 1.67 | 1.79 |
| PAT Margin (%) | -1.71 | 6.73 | 1.89 | 1.24 | 1.45 |
| Cash Profit Margin (%) | 8.15 | 6.73 | 1.89 | 1.24 | 1.45 |
| Performance Ratios | |||||
| ROA(%) | -0.78 | 0.61 | 1.66 | 1.29 | 1.86 |
| ROE(%) | -17.97 | 5.67 | 2.85 | 3.57 | 5.80 |
| ROCE(%) | 1.86 | 0.91 | 3.91 | 5.14 | 7.27 |
| Asset Turnover(x) | 0.46 | 0.09 | 0.87 | 1.04 | 1.28 |
| Sales/Fixed Asset(x) | 0.48 | - | - | - | - |
| Working Capital/Sales(x) | 3.27 | 0.43 | 2.97 | 12.31 | 19.26 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.08 | - | - | - | - |
| Receivable days | 31.39 | 139.03 | 146.04 | 149.32 | 125.56 |
| Inventory Days | 34.08 | 186.11 | - | 1.84 | 13.95 |
| Payable days | 16.60 | - | 84.25 | 136.65 | 128.56 |
| Valuation Parameters | |||||
| PER(x) | - | 58.90 | 92.01 | 20.81 | - |
| PCE(x) | 7.09 | 321.36 | 92.03 | 20.81 | - |
| Price/Book(x) | 6.68 | 17.74 | 2.59 | 0.73 | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 3.06 | 40.21 | 1.74 | 0.11 | 0.13 |
| EV/Core EBITDA(x) | 22.15 | 422.15 | 67.07 | 6.24 | 7.19 |
| EV/EBIT(x) | 77.45 | 422.15 | 67.07 | 6.24 | 7.19 |
| EV/CE(x) | 1.19 | 2.03 | 2.47 | 0.13 | 0.16 |
| M Cap / Sales | 0.58 | 21.63 | 1.74 | 0.26 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 1,077.40 | -41.59 | -46.11 | -24.57 | 96.61 |
| Core EBITDA Growth(%) | 1,605.99 | 114.43 | -21.45 | -26.02 | 201.70 |
| EBIT Growth(%) | 387.96 | 114.43 | -21.45 | -26.02 | 201.70 |
| PAT Growth(%) | -398.72 | 107.62 | -17.59 | -35.43 | 141.23 |
| EPS Growth(%) | -398.72 | 107.58 | -17.57 | -35.43 | 141.25 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 28.73 | 15.25 | - | - | - |
| Current Ratio(x) | 2.22 | 3.64 | 11.67 | 1.16 | 1.09 |
| Quick Ratio(x) | 1.65 | 3.06 | 11.67 | 1.15 | 1.09 |
| Interest Cover(x) | 0.38 | 22.34 | 72.36 | 16.67 | 75.86 |
| Total Debt/Mcap(x) | 0.48 | 0.86 | - | - | - |
Compare Financial Ratios of peers of ARUNJYOTI BIO VENTURES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ARUNJYOTI BIO VENTURES | ₹264.7 Cr | -9.7% | -25.2% | 262% | Stock Analytics | |
| BAJAJ FINSERV | ₹295,255.0 Cr | 2.9% | 9% | 14% | Stock Analytics | |
| AUTHUM INVESTMENT & INFRASTRUCTURE | ₹28,807.4 Cr | -5.4% | -7.3% | 109.9% | Stock Analytics | |
| CHOLAMANDALAM FINANCIAL HOLDINGS | ₹28,435.1 Cr | 2.7% | 4.8% | 32% | Stock Analytics | |
| IIFL FINANCE | ₹14,066.4 Cr | -9.2% | -16.9% | -39.8% | Stock Analytics | |
| CAPRI GLOBAL CAPITAL | ₹13,701.1 Cr | -4.9% | -7.6% | -29.2% | Stock Analytics | |
ARUNJYOTI BIO VENTURES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ARUNJYOTI BIO VENTURES | -9.7% |
-25.2% |
262% |
| SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses
